Cohen Klingenstein LLC Has $8.70 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Cohen Klingenstein LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 37.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,200 shares of the healthcare conglomerate’s stock after selling 10,500 shares during the period. Cohen Klingenstein LLC’s holdings in UnitedHealth Group were worth $8,701,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Sanibel Captiva Trust Company Inc. boosted its position in shares of UnitedHealth Group by 3.4% during the 4th quarter. Sanibel Captiva Trust Company Inc. now owns 69,016 shares of the healthcare conglomerate’s stock worth $34,912,000 after purchasing an additional 2,272 shares in the last quarter. Howard Financial Services LTD. lifted its holdings in shares of UnitedHealth Group by 8.8% in the 4th quarter. Howard Financial Services LTD. now owns 408 shares of the healthcare conglomerate’s stock worth $206,000 after purchasing an additional 33 shares in the last quarter. Verity & Verity LLC increased its position in shares of UnitedHealth Group by 36.9% during the fourth quarter. Verity & Verity LLC now owns 2,052 shares of the healthcare conglomerate’s stock worth $1,038,000 after acquiring an additional 553 shares in the last quarter. Canoe Financial LP lifted its position in UnitedHealth Group by 24.4% in the 4th quarter. Canoe Financial LP now owns 462,100 shares of the healthcare conglomerate’s stock valued at $233,758,000 after acquiring an additional 90,585 shares in the last quarter. Finally, DB Fitzpatrick & Co Inc purchased a new stake in UnitedHealth Group in the 4th quarter valued at $839,000. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Oppenheimer raised their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday. Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Bank of America lowered their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Trading Down 0.1 %

NYSE:UNH opened at $510.03 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a 50-day moving average price of $551.50 and a 200-day moving average price of $562.62. The stock has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.83 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.